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ORIGINAL ARTICLE 
ANAESTHETIC MANAGEMENT OF DIABETIC PATIENTS UNDERGOING 
MAJOR SURGERY USING GLUCOSE INSULIN POTASSIUM INFUSION 
A STUDY OF THIRTY CASES. 
Fazal Hameed Khan, Rehana Kamal 
ABSTRACT 
Thirty diabetic patients undergping major elective surgery were studied to assess the effectiveness of a regimen of 
glucose- insulin- potassium infusion at the Aga Khan University Hospital, Karachi. Out of the 30 patients studied, 
25 were non insulin dependent and 5 insulin dependent. During surgery 24 out of30 patients (80°/e) had acceptable 
glycaemic control i.e. mean blood glucose levels in the range of90-216 mg/100 ml with neither clinical norbiochemicai 
evidence of hypoglycemia or hyperglycaemia. Post operatively, the mean blood glucose level on the day of operation 
was acceptable in 19 patients (63.33°/o). 
During this study, no patient had clinical or biochemical hypoglycemia, neither was there any incidence of serious 
morbidity or mortality attributable to problems with diabetic control. Glucose insulin potassium infusion was found 
to be satisfactory for managing diabetics during major surgery.(JCPSP 1993;3(2):44-49) 
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INTRODUCTION 
Now that infectioils and infestations are well under control due 
to better sanitation, effective protective inoculations and potent 
antibiotics, metabolic and degenerative diseases are the problems 
that the anaesthesiologists have to face, one such disease is 
diabetes melli Ius. It has been estimated that 50% of diabetics will 
need an operation at some time during their !ife1• Diabetic 
patients undergoing surgery are at a higher risk of developing 
complications if the control of diabetes is poor. 
The advent of insulin revolutionized the treatment of diabetic 
patients undergoing surgery, a revolution that was extended by 
the discovery of antibiotics. Inspite of all these improvements in 
the management of diabetic patient, surgery carries a significant 
mortality and morbidity even in good centres'·'. The major causes 
of morbidity and mortality in diabetic patients were and still are 
infection'·' and myocardial disease'. It is obvious that problems 
may arise during and after surgery in diabetics and that these 
problems are exacerbated by poor control of diabetes. A recent 
retrospective study suggests, however, that if diabetes is well 
controlled, postoperative morbidity is not increased by diabetes'. 
There is obviously a need for a logical straightforward set of 
guidelines for the management of diabetes in patients undergoing 
major surgery. At present there are a multitude of recommended 
regimens8-12• One such regimen is the use of glucose insulin 
potassium infusion. This study was designed to see whether 
glucose insulin potassium infusion (GIK) provides adequate 
diabetic control during surgery or not and to see whether it 
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reduces mortality and morbidity in diabetic patient under going 
. I 
maJor surgery. 
MATERIAL AND METHODS 
Thirty diabetic patients of ASA I & II scheduled for major elective : 
surgery were studied. Five ofthese patients were insulin-depend· 1 
ent and the rest were non-insulin-dependent. Major surgery was ~ 
defined as operations lasting for more than one hour which are 
likely to interfere with diet and normal diabetic management e.g. 
cholecystectomy, major vascular reconstruction and bowel resec-
tion. These patients were admitted forty-eight hours before 1 
surgery for stabilization of their blood glucose level and they were ! 
placed on soluble insulin according to sliding scale based on i 
blood glucose estimations. These patients were scheduled first on 
the operating list. If they were on the afternoon list, then a light 
breakfast was given at 6 a.m. 
All patients received Tab. diazepam 0.15mglkg two hours before 
surgery with sips of water. Morning dose oflnsulin was omitted 
and fasting blood sugar and serum potassium done two hours 
preoperatively. Depending on these results glucose insulin potas-
sium infusion was started one hour preoperatively. Dose of 
insulin and potassium was according to the G IK regimen as given 
in Table I. 
Anaesthesia was induced with thiopentone sodium5 mg/ kg body 
weight and endotracheal intubation carried out after giving 
suxamethonium 1.5 mglkg body weight. Anaesthesia was main. 
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TABLE I 
GLUCOSE INSULIN POTASSIUM DRIP REGIMEN 
l. Use a separate drip for glucose-insulin-potassium infusion. 
2. Flush the given set with 25m! of glucose-insulin-potassium solution before starting the infusion. 
Blood sugar Soluble Potassium Glucose Rate of 
Insulin infusion infusion 
<90mgll00 ml 5 units !Ommols 500ml10% IOOmllhr 
90-180mgll00ml 10 units !Ommols 500mll0% IOOmllhr 
!80-360mgll OOml 15 units !Ommols 500ml!O% IOOmllhr 
> 360mg/100ml 20 units !Ommols 500ml!O% IOOmllhr 
3. Estimate blood sugar and potassium as below : 
BLOOD SUGAR - one hour after starting drip 
-
every hour during surgery 
-
4-hourly post-operatively 
SERUM POT AS SlUM 
-
4 hourly intra-operatively 
- 8 hourly post-operatively 
4. Manage as given below: 
-
If blood sugar< 60mgll00ml, stop G.I.K. Regime and give 25m! of 50% 
glucose & check blood sugar after 15 minutes 
-
If serum potassium is less than 3 mmol/L add 20 mmols of potassium to 500ml 10% DfW 
-
If serum potassium> 5mmol/L stop potassium 
tained with nitrous oxide and oxygen in a ratio of70:30 supple-
mented with halothane 0.5%. Muscle relaxation was obtained 
with pancuronium 0.1 rug/kg body weight and analgesia by 
pethidine 0.8 mglkg body weight. The neuromuscular blockade 
was reversed with neostigmine and atropine. 
The glucose insulin potassium infusion was delivered through an 
IVAC pump at a rate of lOOmis/hour and continued throughout 
surgery. During this period blood glucose was monitored hourly 
with glucometer using glucostix and serum potassium checked 4 
hourly. The blood sugar was also sent to the laboratory every 2 
hours (The laboratory result ofglucosecomparedfavourably with 
the glucometer). The insulin content of infusion was changed 
every hour depending on the results of blood glucose. The 
maintenance fluid used was normal saline administered through 
a separate cannula and blood replacement was done whenever 
needed. 
Post-operatively, in all these patients the glucose insulin potas-
sium infusion was continued till the patient started oral feeding. 
During this period blOOd sugar was checked 4 hourly and serum 
potassium 8 hourly. When patient had resume oral feeding, blood 
sugar was checked before each main meal and then subcutaneous 
insulin was given according to sliding scale and insulin depend-
ent diabetic patients were brought to original preoperative insulin 
regimen in 2-3 days. In the insulin-independent diabetic patients, 
when the postoperative insulin requirement becomes less then 20 
units per day, then their diabetes was controlled by diet or oral 
hypoglycemic drugs depending on the treatment on which they 
were prior to surgery. 
RESULTS 
The demographic detail ofthepatientsand the surgical procedure 
performed on them is given in Table II. 
Glycaemic control 
Fasting blood glucose on the day of operation was acceptable in 
all the patients (Table III). Preoperative fasting blood glucose in 
the optimal range (90-180 mg/100 ml) was achieved in 25 out of 
30 patients (83.33%). 
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TABLE II 
DETAILS OF PATIENTS AND SURGICAL PROCEDURE 
S.no AGE SEX WEIGHT ASSOCIATED TYPE OF SURGICAL 
(yrs) (kg) PROBLEMS DIABETES PROCEDURE 
1 60 F 86.0 Hypertension NIDDM* Cholecystectomy 
2 55 M 86.0 - NIDDM Pyelolithotomy 
3 55 F 61.5 Hypertension NIDDM Cholecystectomy 
4 50 M 86.5 I st Degree Heart Block NIDDM Cholecystectomy 
5 60 M 75.0 - NIDDM Thoracotomy 
6 35 M 50.5 - NIDDM Splenectomy 
7 68 M 87.5 - NIDDM Nephrectomy 
8 55 M 50.0 - NIDDM Hemicolectomy 
9 45 F 55.0 Hypertension IDDM** Abd. Hysterectomy 
10 65 M 75.0 - NIDDM Total Hip Replacement 
11 58 M 78.0 Right Bundle Branch Block NIDDM Cholecystectomy 
12 70 M 65.0 - NIDDM Total Hip Replacement 
13 62 M 73.0 - NIDDM Nephrectomy 
14 43 F 51.8 NIDDM Exploratory Laparotomy I -
15 54 F 80.0 - NIDDM Cholecystectomy 
16 60 F 70.0 - NIDDM Cholecystectomy 
17 58 F 67.0 Ischaemic Heart Disease NIDDM Modified Radical Mastectomy 
!8 51 F 81.6 - NIDDM Incisional Hernia Repair 
19 48 F 65.0 - NIDDM Cholecystectomy 
20 53 F 60.0 Hypertension NIDDM Exploratory Laparotomy 
21 60 M 50.0 Hypertension NIDDM Internal Fixation # Shaft Femur 
22 38 M 54.0 - IDDM Thoracotomy 
23 51 F 62.5 - NIDDM Cholecystectomy 
24 65 M 64.0 Peripheral Vascular Disease NIDDM Femoro Popliteal Grafting 
25 48 M 70.0 - NIDDM Exploratory Laparotomy 
26 4(} M 53.0 - NIDDM Cholecystectomy 
27 50 F 65.0 Hypertension NIDDM Cholecystectomy 
28 68 F 60.0 - NIDDM Exploratory Laparotomy 
29 52 M 83.6 - NIDDM Cholecystecctomy 
30 50 F 80.0 Hypertension NIDDM Cholecystectomy 
*NIDDM : non insulin dependent diabetes mellitus 
**IDDM : insulin dependent diabetes mellitns 
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TABLE ill 
PRE-OPERATIVE 
BLOOD SERUM 
SUGAR POTASSIUM 
(mgl100ml) (mmol/L) 
121 4.1 
!54 4.5 
160 3.5 
112 3.8 
199 3.3 
!50 4.4 
174 3.5 
143 4.0 
175 3.5 
160 4.5 
!57 4.1 
166 5.3 
114 3.9 
165 4.4 
169 5.3 
!52 3.3 
198 3.9 
152 3.1 
180 4.3 
161 4.4 
122 3.4 
154 4.1 
185 4.3 
187 4.8 
219 4.7 
175 4.5 
187 4.2 
110 4.3 
135 4.1 
165 4.5 
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POST -OPERATIVE 
MEAN BLOOD SUGAR SERUM 
(mgllOOml) POTASSIUM 
intra post 
operative operative (mmoi/L) 
!98.3 196.2 3.5 
203.0 213.2 4.0 
233.0 224.5 4.2 
185.3 190.5 3.3 
185.0 125.7 3.8 
!96.3 197.5 4.1 
200.0 250.0 3.8 
213.0 155.7 4.3 
225.0 280.0 3.8 
215.0 202.0 4.3 
203.3 210.7 4.6 
273.3 254.2 5.1 
171.0 218.7 3.5 
210.0 202.0 4.3 
191.6 199.0 5.1 
203.3 189.7 3.5 
220.0 231.5 3.5 
206.6 168.5 3.8 
171.3 198.7 3.6 
211.6 193.2 4.1 
217.6 217.7 3.7 
179.6 237.5 3.5 
206.6 228.7 3.8 
211.6 211.2 3.6 
251.6 198.7 4.5 
195.0 268.7 4.5 
193.3 175.0 4.0 
144.0 167.5 3.8 
154.0 188.7 3.9 
211.6 220.0 4.0 
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Acceptable glycaemia control intraoperatively and postoperatively 
was defined as mean blood glucose levels in the range of 90-
216mg/IOOml with neither clinical nor biochemical hypoglycac-
mia (blood glucose less than 54mg%). During the operation 24 
out of the 30 patients (80%) had acceptable glycaemic control. 
Postoperatively in 19 patients (63.33%) the mean blood glucose 
on the day of operation was acceptable (Table III). 
During this study, no patient had clinical or biochemical hypogly-
caemia, neither was there any incidence of serious hyperglycae-
mia or ketoacidosis. There was no serious morbidity or mortality 
attributable to problems with diabetic control. 
SERUM POTASSIUM CHANGES 
The serum potassium on the pre- and first post -operative day is 
shown is Table Ill. On the 1st postoperative day, 6 patients had 
serum potassium ranging between 3-3.5 mmol/L but none had 
less then 3.0. Two patients had slightly elevated postoperative 
potassium concentration (5.1 mmoi/L in both instances) but in 
these patients the preoperative values were comparatively high 
(5.3 mmol/L). 
DISCUSSION 
The metabo1ic changes which occur after major surgery have 
been widely described in literature". The primary aim of 
metabolic management in a diabetic patient undergoing major 
surgery is the avoidance of excess morbidity and mortality 
attributable to diabetes. Normoglycaemia is not necessary". The 
objective is to achieve a level of glycaemic control which carries 
the least risk ofhypoglycaemia, in the intra- and early postopera-
tive period. It is reasonable to aim for a glucose level of 90-216 
mg/100 ml on the day of surgery15, especially as a recent study in 
patients undergoing major vascular surgery has shown that 
diabetic patients with blood glucose concentrations in this range 
had a morbidity and mortality identical to that of non-diabetic 
patients 16. 
When glucose insulin potassium infusion was used 
intraoperatively, mean blood glucose values were acceptable at 
all times, and overall adequate control was achieved in 80% of 
cases. Bowen et al' observed hypoglycaemia in 2 of 27 patients 
managed with GIK and they recommended that blood glucose 
level should never be allowed to fall below 90mg% because of the 
obvious hazards of hypoglycaemia. 
In view of the association of hyperglycaemia with high and 
hypoglycaemia with low insulin requirements, it would be useful 
if the insulin requirement in the GIK could be accurately pre-
dicted prior to operation. Patients undergoing major surgery arc 
more likely to have high insulin requirements, but it is preferable 
to monitor blood glucose hourly and regulate the insulin dose 
accordingly. 
April · June 1993 
Accurate blood glucose moni taring is performed by using glucostix 
and glucometer. Results from the laboratory are usually delayed 
and costly for the patient. It is demonstrated in this study that an 
acceptable standard ofblood glucose monitoring can be achieved 
with glucometer. Direct comparison of results using GIK infusion 
with those using other regimens is difficult, and indeed there have 
been few assessments in a routine clinical setting. The use of 
fractional doses of intermediate acting insulin on the day of 
operation is illogical, difficult to use in practice, and frequently 
associated with poor control'. Two acceptable alternatives other 
than GIK are available. Anderson10 suggested giving twice daily 
short and intermediate acting insulin on the day of surgery and 
substituting the normal carbohydrate intake by intravenous glu-
cose. The problems with this regimen are that it is more complex, 
that it depends on adequate subcutaneous perfusion and the 
patient is vulnerable to interruption of the glucose infusion. 
The use of separate insulin and glucose infusion is a possible way 
of achieving very precise g1ycaemic control but requires very 
close monitoring to obtain good results 11 With separate infusions, 
hypoglycaemia is a danger iftechnical failure occurs, though it 
is not known whether this occurs more commonly than with GIK 
regimen. 
This study was carried out on patient admitted for routine surgery, 
but since this regimen can be employed at any hour of the day or 
night it may also be suitable for emergency surgical patients. 
It is also suggested that insulin glucose potassium infusion be 
administered through a separate cannula from that used for other 
infusions required during major surgery and anaesthesia when 
other fluids may need to be infused very rapidly. There was no 
incidence of thrombophlebitis during the time of study and the 
patients tolerated the regimen well. Although an IV ACpumpwas 
used to maintain constant infusion of IOOml!hour if it is not 
available then Soluset infusion set can be easily used in its place. 
In summary it is suggested that glucose insulin potassium infua 
sian regimen is suitable for the routine management of diabetic 
patients undergoing major surgery specially in district hospitals 
ofPakistan where good laboratory facilities are not available. The 
regimen cannot however be used in the blind unmonitored 
manner implied by some authors". The search for a simple, 
arbitrary, insulin regimen for the management of diabetics 
undergoing major surgery is a search for a dangerous illusion. 
Diabetics vary in their response to insulin and in their metabolic 
response to surgery. The requirements for acceptable metabolic 
control in the diabetic during major surgery arc the use of a logical 
regimen, the careful and frequent monitoring of blood glucose 
and prompt and appropriate changes in therapy. 
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